Stocks and InvestingStocks and Investing
Fri, September 1, 2023
Thu, August 31, 2023
Wed, August 30, 2023
Tue, August 29, 2023

Rick Bienkowski Reiterated (BEAM) at Buy and Held Target at $56 on, Aug 29th, 2023


Published on 2024-10-28 06:10:33 - WOPRAI, Rick Bienkowski
  Print publication without navigation


Rick Bienkowski of Cantor Fitzgerald, Reiterated "Beam Therapeutics Inc." (BEAM) at Buy and Held Target at $56 on, Aug 29th, 2023.

Rick has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 3 agree with Rick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Richard Law of "Credit Suisse" Maintained at Hold with Increased Target to $47 on, Wednesday, August 9th, 2023
  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $42 on, Thursday, May 11th, 2023


This is the rating of the analyst that currently disagrees with Rick


  • Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Decreased Target to $56 on, Wednesday, August 9th, 2023